Should 500K more young people be on statins? Guidelines say yes, JAMA reports

If physicians followed new cholesterol guidelines for statin use, almost half a million young people in the U.S. would be prescribed a statin, a JAMA Pediatrics study concludes. Some 483,500 people aged 17 to 21 years would be in line for the cholesterol drugs under the new recommendations from the U.S. National Heart, Lung and Blood Institute. Report

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.